A new study shows that while RSV mostly affects younger kids, the often-overlooked human metapneumovirus also hospitalizes ...

In experiments described in the journal Nature Communications, the team reports how they discovered two rare antibodies that, if combined into a “cocktail,” can block infection by all four of those ...

Researchers at Griffith University's Institute for Glycomics have moved a step closer to identifying a treatment for the dreaded Human parainfluenza virus (hPIV). These highly-infectious viruses ...

Human parainfluenza viruses, or HPIVs, are the leading cause of childhood respiratory infections, responsible for 30% to 40% of illnesses like croup and pneumonia.

There’s still very little flu circulating, but other viruses — including parainfluenza viruses and common human coronaviruses, which cause colds — are having an out-of-season resurgence in 2021.

Human parainfluenza viruses are a major cause of respiratory infections that particularly affect young children and immunocompromised individuals. These viruses present a significant global health ...

The virus can be more severe in young children and in older adults, and the U.S. typically sees some 20,000 to 25,000 influenza deaths per year, though that number can reach as high as 60,000 ...

From populations to hosts to cells In the second half of the 20th century, not only did evidence of how one virus can block another begin to emerge in the lab, but certain epidemiological patterns of ...

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors. Nature Communications, 2014; 5: 5268 DOI: 10.1038/ncomms6268 ...

Griffith University. "Combating human parainfluenza virus." ScienceDaily. www.sciencedaily.com / releases / 2015 / 02 / 150211124037.htm (accessed April 19, 2025).

May 23, 2010 (Dallas, Texas) — An outbreak of human parainfluenza virus type 3 (hPIV-3) infection among recipients of hematopoietic stem cell transplants (HSCTs) in an outpatient clinic ...